Get the Stockscreener App
9.65
3.32%
0.31
After Hours:
9.84
0.19
+1.97%
Tenax Therapeutics Inc stock is traded at $9.65, with a volume of 168.42K.
It is up +3.32% in the last 24 hours and up +36.11% over the past month.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
See More
Previous Close:
$9.34
Open:
$9.45
24h Volume:
168.42K
Relative Volume:
1.60
Market Cap:
$60.25M
Revenue:
-
Net Income/Loss:
$-14.56M
P/E Ratio:
-0.5737
EPS:
-16.82
Net Cash Flow:
$-12.46M
1W Performance:
+2.33%
1M Performance:
+36.11%
6M Performance:
+64.12%
1Y Performance:
+63.84%
1-Day Range:
$9.44
$9.91
1-Week Range:
$8.76
$9.91
52-Week Range:
$4.63
$9.91
Tenax Therapeutics Inc Stock (TENX) Company Profile
Name
Tenax Therapeutics Inc
Sector
Industry
Phone
919-855-2100
Address
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Compare TENX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
9.65 | 58.38M | 0 | -14.56M | -12.46M | -16.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | Piper Sandler | Overweight |
| Oct-24-24 | Initiated | Leerink Partners | Outperform |
| Oct-14-24 | Initiated | Guggenheim | Buy |
| Sep-30-24 | Initiated | William Blair | Outperform |
| May-18-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Dec-16-14 | Initiated | MLV & Co | Buy |
| Nov-18-14 | Initiated | WallachBeth | Buy |
View All
Tenax Therapeutics Inc Stock (TENX) Latest News
Tenax Therapeutics (NASDAQ:TENX) Insider Stuart Rich Buys 1,500 Shares - MarketBeat
Tenax Therapeutics (NASDAQ:TENX) Insider Stuart Rich Buys 2,500 Shares - MarketBeat
TENAX Therapeutics CMO Stuart Rich Acquires 5,000 Shares - TradingView
Officer/Dir Rich Buys 5,000 ($45.6K) Of Tenax Therapeutics Inc [TENX] - TradingView
Tenax Therapeutics Inc. (TENX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What technical signals suggest for Tenax Therapeutics Inc. stock2025 Macro Impact & Short-Term High Return Strategies - Newser
Behavioral Patterns of TENX and Institutional Flows - news.stocktradersdaily.com
Why Tenax Therapeutics Inc. stock could benefit from AI revolution2025 Trading Volume Trends & Comprehensive Market Scan Insights - Newser
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
What analysts say about Tenax Therapeutics Inc. stockMean Reversion Trades & Market-Leading Growth Rates - earlytimes.in
Tenax Therapeutics to Participate in Upcoming Investor Conferences - Investing News Network
Tenax Therapeutics (Nasdaq: TENX) plans Dec. 2 and 4 fireside chats at Evercore, Piper - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
(TENX) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
GIORDANO CHRISTOPHER THOMAS Insider Trades - Nasdaq
Is Tenax Therapeutics Inc. stock a safe buy before earningsEarnings Growth Report & Reliable Volume Spike Trade Alerts - newser.com
Giordano buys Tenax Therapeutics (TENX) shares worth $19,999 By Investing.com - Investing.com Nigeria
Insider Buying: Christopher Giordano Acquires Shares of Tenax Therapeutics Inc (TENX) - GuruFocus
Giordano buys Tenax Therapeutics (TENX) shares worth $19,999 - Investing.com
CEO Giordano Buys 2,605 ($20K) Of Tenax Therapeutics Inc [TENX] - TradingView
[Form 4] TENAX THERAPEUTICS, INC. Insider Trading Activity - Stock Titan
Tenax Therapeutics interim CFO McGauley buys shares worth $58,164 By Investing.com - Investing.com Nigeria
Insider Buying: June Almenoff Acquires Shares of Tenax Therapeutics Inc (TENX) - GuruFocus
Tenax Therapeutics interim CFO McGauley buys shares worth $58,164 - Investing.com
Understanding Tenax Therapeutics Inc.’s price movementProfit Target & Fast Moving Trade Plans - newser.com
TENAX Therapeutics Executives Increase Their Holdings - TradingView
Almenoff June Sherie, director at Tenax Therapeutics, buys $14944 in shares - Investing.com Canada
CFO McGauley Buys 8,000 ($58.2K) Of Tenax Therapeutics Inc [TENX] - TradingView
TENAX Therapeutics Director June Sherie Almenoff Acquires 1,993 Shares - TradingView
Can machine learning forecast Tenax Therapeutics Inc. recovery2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com
Why Tenax Therapeutics Inc. stock is a must watch in 20252025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com
How sentiment analysis helps forecast Tenax Therapeutics Inc.2025 EndofYear Setup & High Conviction Trade Alerts - newser.com
Historical volatility pattern of Tenax Therapeutics Inc. visualizedPortfolio Value Summary & Accurate Trade Setup Notifications - newser.com
Tenax Therapeutics reports Q3 EPS (40c), consensus ($1.12) - MSN
Forecasting Tenax Therapeutics Inc. price range with options dataWeekly Trade Report & Risk Controlled Swing Alerts - newser.com
Q4 EPS Forecast for Tenax Therapeutics Raised by Analyst - Defense World
This analyst loves Tenax Therapeutics - Cantech Letter
Tenax Therapeutics Inc Stock (TENX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):